Pituitary and ovarian suppression after early follicular and midluteal administration of a lhrh agonist in a depot formulation: Decapeptyl cr

Gynecological Endocrinology

Volumn 6, Issue 3, 1992, Pages 153-161

  Broekmans, F J ^a   Bemardus, R E ^a   Berkhout, G ^a   Schoemaker, J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Depot Formulation; Luteinizing Hormone Releasing Hormone Agonist; Pituitary; Triptorelin

Indexed keywords

ESTROGEN; FOLLITROPIN; GONADORELIN AGONIST; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE; STEROID; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; ESTROGEN RELEASE; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HORMONE INHIBITION; HUMAN; HUMAN EXPERIMENT; HYPOPHYSIS FUNCTION; INTRAMUSCULAR DRUG ADMINISTRATION; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; MENSTRUATION; NORMAL HUMAN; OVARY FUNCTION; PRIORITY JOURNAL; STEROID BLOOD LEVEL;

ADULT; DELAYED-ACTION PREPARATIONS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; LUTEINIZING HORMONE; OVARY; PITUITARY GLAND; PROGESTERONE; TRIPTORELIN;

EID: 0026488150     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599209015549     Document Type: Article

References (47)

1. Gonadotropin-releasing hormone and its analogues
2. Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist
3. Endocrinologic and clinical evaluation following a single administration of a gonadotropin-releasing hormone agonist (Zoladex), in depot formulation, to premenopausal women
4. 6 -LHRH microcapsules for the treatment of endometriosis
5. 6 -GnRH
6. 6-LHRH microcapsules: pilot studies with two protocols
7. First experiences and results with the GnRH agonist Decapeptyl CR in the treatment of PCO patients
8. 6-luteinizing hormone-releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer
9. Pharmacodynamics, pharmacokinetics and bioavailability of the prolonged LH-RH agonist Decapeptyl SR
10. Radioimmunoassay for 6-D-Tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long acting microcapsules formulation
11. Luteinizing hormone secretion patterns in boys at the onset of puberty measured using a highly sensitive immunoradiometric assay
12. A distribution free test for tumor-growth curve analyses with application to an animal tumor immunotherapy experiment
13. Mechanisms of gonadotropin-releasing hormone agonist action in the human male
14. Studies on the effect of gonadotropin-releasing hormone and its agonist on human luteal steroidogenesis in vitro
15. The effect of luteinizing hormone-releasing hormone and its agonist on cultured human granulosa cells
16. Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells
17. Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist
18. Specificity of gonadotropin-releasing hormone binding sites of the human corpus luteum: comparison with receptors of rat pituitary gland
19. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men
20. Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis
21. Absence of immunoreactive luteinizing hormone following gonadotropin-releasing hormone agonist therapy in women with endometriosis
22. Blocage hypophysaire par un analogue de la gonadoreline le DTrp6-GnRH à liberation pro-longée avant induction de l'ovulation
23. Binding affinity and biological activity of gonadotropin-releasing hormone analogs in isolated pituitary cells
24. Resistance to enzymic degradation of GnRH analogues possessing increased biological activity
25. 6 and exogenous luteinizing hormone-releasing hormone
26. Gonadotropin releasing hormone receptors: characterization, physiological regulation and relationship to reproductive function
27. Agonist-induced regulation of pituitary receptors for gonadotropin-releasing hormone
28. Gonadotrophin-releasing hormone: its actions and receptors
29. Agents that decrease gonadotropin-releasing hormone (GnRH) receptor internalization do not inhibit GnRH-mediated gonadotrope desensitization
30. Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in poly-cystic ovarian disease
31. Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women
32. Gonadotropin releasing hormone agonist suppressive treatment of ovarian function decreases LH-β and bioactive LH but maintains elevated levels of LH-α
33. Long-acting gonadotropin releasing hormone agonist implant causes variable duration of suppression of ovarian steroid and inhibin secretion
34. Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy
35. Evidence to support a follicle-stimulating hormone threshold theory for follicle selection in ewes chronically treated with gonadotrophin-releasing hormone agonist
36. Effect of inhibin-like activity on LH-RH stimulated release of FSH by pituitary glands from female rats in vitro
37. Evidence of differential control of FSH and LH secretion by gonadotrophin-releasing hormone (GnRH) from the use of a GnRH antagonist
38. La GnRH et ses analogues structure, mecanisme d'action et apphcations therapeutiques
39. Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonist (goserelin) - lack of shrinkage of uterine fibroids
40. 6 -luteinizing hormone-releasing hormone
41. Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist
42. Variation of pituitary response to synthetic LRF during different phases of the menstrual cycle
43. The two pools of pituitary gonadotropin: regulation during the menstrual cycle
44. 6-LHRH
45. 6-LHRH, gonadotropins and sequential embryo transfer
46. Ovarian programming and GIFT